MX2007008255A - Tioeteres de tripeptido y tetrapeptido. - Google Patents

Tioeteres de tripeptido y tetrapeptido.

Info

Publication number
MX2007008255A
MX2007008255A MX2007008255A MX2007008255A MX2007008255A MX 2007008255 A MX2007008255 A MX 2007008255A MX 2007008255 A MX2007008255 A MX 2007008255A MX 2007008255 A MX2007008255 A MX 2007008255A MX 2007008255 A MX2007008255 A MX 2007008255A
Authority
MX
Mexico
Prior art keywords
tripeptide
bone marrow
tumor cells
chemotherapeutic agents
tetrapeptide
Prior art date
Application number
MX2007008255A
Other languages
English (en)
Spanish (es)
Inventor
Steven R Schow
Louise Robinson
Reyna J Simon
Natalia Aurrecoechea
Andrew B Kelson
Robert W Macsata
Anthony J Sanchez
Nicholas M Santiago
Original Assignee
Telik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telik Inc filed Critical Telik Inc
Publication of MX2007008255A publication Critical patent/MX2007008255A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2007008255A 2005-01-06 2006-01-04 Tioeteres de tripeptido y tetrapeptido. MX2007008255A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64193205P 2005-01-06 2005-01-06
PCT/US2006/000219 WO2006074249A1 (en) 2005-01-06 2006-01-04 Tripeptide and tetrapeptide thioethers

Publications (1)

Publication Number Publication Date
MX2007008255A true MX2007008255A (es) 2007-09-11

Family

ID=36123437

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2007008255A MX2007008255A (es) 2005-01-06 2006-01-04 Tioeteres de tripeptido y tetrapeptido.
MX2007008254A MX2007008254A (es) 2005-01-06 2006-01-05 Sulfonas de tripeptidos y tetrapeptidos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2007008254A MX2007008254A (es) 2005-01-06 2006-01-05 Sulfonas de tripeptidos y tetrapeptidos.

Country Status (24)

Country Link
US (2) US7129215B2 (https=)
EP (2) EP1833978B1 (https=)
JP (2) JP4903716B2 (https=)
KR (2) KR101244609B1 (https=)
CN (2) CN101090977B (https=)
AR (2) AR051889A1 (https=)
AT (2) ATE410520T1 (https=)
AU (2) AU2006204022B2 (https=)
BR (2) BRPI0606520A2 (https=)
CA (2) CA2587284C (https=)
DE (2) DE602006003064D1 (https=)
DK (2) DK1833978T3 (https=)
EA (2) EA200701398A1 (https=)
ES (2) ES2314890T3 (https=)
HR (2) HRP20090128T3 (https=)
IL (2) IL182836A (https=)
MX (2) MX2007008255A (https=)
NZ (2) NZ555362A (https=)
PL (2) PL1833978T3 (https=)
PT (2) PT1833978E (https=)
SI (2) SI1833978T1 (https=)
TW (2) TWI317739B (https=)
WO (2) WO2006074249A1 (https=)
ZA (2) ZA200704487B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8198247B2 (en) 2004-12-21 2012-06-12 Telik, Inc. Process for and intermediates in the preparation of canfosfamide and its salts
BRPI0606520A2 (pt) * 2005-01-06 2009-06-30 Telik Inc tripeptìdeo e tetrapeptìdeo tioéteres
US20070154963A1 (en) * 2005-12-30 2007-07-05 Danying Cai Method to determine whether a compound is a cellular GSTpi inhibitor
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
WO2008056207A1 (en) * 2006-11-08 2008-05-15 Chongxi Yu Transdermal delivery systems of peptides and related compounds
AU2016213759B2 (en) * 2006-11-08 2018-03-29 Chongxi Yu Transdermal delivery systems of peptides and related compounds
WO2008149181A1 (en) 2007-06-04 2008-12-11 Techfields Inc Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
WO2010065936A1 (en) 2008-12-04 2010-06-10 Chongxi Yu High penetration compositions and their applications
DE102008060888A1 (de) 2008-12-09 2010-06-10 Evonik Stockhausen Gmbh Verfahren zur Herstellung von Acrolein umfassend die Aufarbeitung einer Rohglycerin-Phase
EP2427475B1 (en) 2009-05-08 2020-11-04 Techfields Biochem Co., Ltd. High penetration prodrug compositions of peptides and peptide-related compounds
CA2797458A1 (en) * 2010-06-07 2011-12-15 Telik, Inc. Tablet formulation of ezatiostat
JP2013528214A (ja) 2010-06-07 2013-07-08 テリック,インコーポレイテッド 結晶性エザチオスタット塩酸塩非溶媒和物d型の調製
US20130035389A1 (en) * 2011-08-05 2013-02-07 Telik, Inc. Methods for treating myelodysplastic syndrome with ezatiostat
JP5970439B2 (ja) * 2013-09-20 2016-08-17 チョンシー ユー ペプチド及び関連化合物の経皮送達システム
CN106146616A (zh) * 2015-04-03 2016-11-23 浙江海正药业股份有限公司 环肽类化合物及其制备和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599903A (en) 1992-04-03 1997-02-04 Terrapin Technologies, Inc. Glutathione analogs and paralog panels comprising glutathione mimics
US5556942A (en) 1991-04-29 1996-09-17 Terrapin Technologies, Inc. Glutathione S-transferase-activated compounds
US5786336A (en) * 1991-04-29 1998-07-28 Terrapin Technologies, Inc. Target-selective protocols based on mimics
US5955432A (en) 1992-04-03 1999-09-21 Terrapin Technologies, Inc. Metabolic effects of certain glutathione analogs
US5767086A (en) 1992-04-03 1998-06-16 Terrapin Technologies, Inc. Bone marrow stimulation by certain glutathione analogs
CA2105492C (en) * 1993-09-03 2000-02-01 Lawrence M. Kauvar Glutathione analogs and paralog panels comprising glutathione mimics
US5908919A (en) * 1993-10-01 1999-06-01 Terrapin Technologies Urethane mediated, GST specific molecular release systems
JPH11507056A (ja) * 1995-06-07 1999-06-22 テラピン テクノロジーズ、インク. グルタチオンアナログの代謝的効果
AU4124697A (en) * 1996-09-02 1998-03-26 Manchester Metropolitan University, The S-blocked glutathiones
TW576838B (en) * 1998-04-16 2004-02-21 Teijin Ltd Glutathione derivatives and application form thereof
ATE286741T1 (de) 1999-01-27 2005-01-15 Telik Inc Glutathioneanaloge enthaltende therapeutische zusammensetzungen
US7029695B2 (en) 2001-07-10 2006-04-18 Telik, Inc. Therapeutic compositions containing glutathione analogs
TWI323662B (en) * 2002-11-15 2010-04-21 Telik Inc Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
BRPI0606520A2 (pt) * 2005-01-06 2009-06-30 Telik Inc tripeptìdeo e tetrapeptìdeo tioéteres

Also Published As

Publication number Publication date
SI1833842T1 (sl) 2009-04-30
DE602006003064D1 (en) 2008-11-20
EP1833978A1 (en) 2007-09-19
EA200701398A1 (ru) 2007-12-28
US20060148719A1 (en) 2006-07-06
TW200635949A (en) 2006-10-16
PL1833842T3 (pl) 2009-04-30
JP4903717B2 (ja) 2012-03-28
PL1833978T3 (pl) 2009-04-30
KR20070104391A (ko) 2007-10-25
BRPI0606396A2 (pt) 2009-06-23
EA200701399A1 (ru) 2008-02-28
CA2587284C (en) 2014-03-25
CN101080418A (zh) 2007-11-28
US20060160749A1 (en) 2006-07-20
AR051890A1 (es) 2007-02-14
KR20070091611A (ko) 2007-09-11
AU2006203901B2 (en) 2011-06-02
AU2006203901A1 (en) 2006-07-13
JP2008526880A (ja) 2008-07-24
PT1833842E (pt) 2008-12-11
NZ555361A (en) 2009-05-31
DK1833978T3 (da) 2009-02-09
TW200635948A (en) 2006-10-16
CA2587284A1 (en) 2006-07-13
AU2006204022B2 (en) 2011-01-20
MX2007008254A (es) 2007-09-11
IL183107A0 (en) 2007-09-20
SI1833978T1 (sl) 2009-04-30
NZ555362A (en) 2009-05-31
EP1833978B1 (en) 2008-10-08
JP2008526859A (ja) 2008-07-24
CA2587310A1 (en) 2006-07-13
US7129215B2 (en) 2006-10-31
KR101244609B1 (ko) 2013-03-25
WO2006074249A1 (en) 2006-07-13
HRP20090134T3 (hr) 2009-04-30
IL183107A (en) 2010-11-30
HK1106778A1 (en) 2008-03-20
JP4903716B2 (ja) 2012-03-28
EP1833842A1 (en) 2007-09-19
TWI317738B (en) 2009-12-01
PT1833978E (pt) 2008-12-02
HK1106796A1 (en) 2008-03-20
ATE410440T1 (de) 2008-10-15
CN101090977B (zh) 2013-04-10
ZA200704488B (en) 2008-09-25
ES2314891T3 (es) 2009-03-16
AR051889A1 (es) 2007-02-14
DK1833842T3 (da) 2009-02-09
ZA200704487B (en) 2008-09-25
US7192918B2 (en) 2007-03-20
ATE410520T1 (de) 2008-10-15
EP1833842B1 (en) 2008-10-08
DE602006003063D1 (de) 2008-11-20
ES2314890T3 (es) 2009-03-16
CN101090977A (zh) 2007-12-19
WO2006074409A9 (en) 2006-12-14
TWI317739B (en) 2009-12-01
AU2006204022A1 (en) 2006-07-13
CA2587310C (en) 2013-11-12
WO2006074409A1 (en) 2006-07-13
BRPI0606520A2 (pt) 2009-06-30
HRP20090128T3 (hr) 2009-04-30
IL182836A (en) 2010-11-30
IL182836A0 (en) 2007-08-19

Similar Documents

Publication Publication Date Title
TW200635948A (en) Tripeptide and tetrapeptide thioethers
SG127738A1 (en) Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, pharmaceutical preparations containing these compounds
MXPA03007837A (es) Composiciones para suministrar bisfosfonatos.
UA91512C2 (ru) Коньюгати олигомеров инсулина, их композиция (варианты) и применение
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
AU2274201A (en) Compounds and compositions for delivering active agents
IL153297A0 (en) Compounds and compositions for delivering active agents
MY143795A (en) Tetrahydropyridoindole derivatives
MX2010003868A (es) Cis-imidazolinas quirales.
TNSN07322A1 (en) Pyrimidine derivatives for treatment of hyperproliferative disorders
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
GEP20115231B (en) 2-amino-7,8-dihydro-6h-pyrido [4,3-d] pyrimidin-5-ones
MXPA05013549A (es) Derivados de tienopirimidina como inhibidores del canal de potasio.
MXPA04003674A (es) Uso mejorado de compuesto antitumoral en terapia de cancer.
EP2279732A3 (en) Compounds and compositions for delivering active agents
IL150953A0 (en) A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer
TW200626553A (en) Novel compounds
TW200727903A (en) Stable pharmaceutical compositions of 5, 10 methylenetetrahydrofolate
SI1638582T1 (sl) Uporaba hialuronske kisline za pripravo sestav za zdravljenje ponavljajoäśih se aft v ustni votlini
MY133682A (en) Substituted pyrroles
MX9702671A (es) Derivados metalocenicos de diariletileno, metodos de preparacion y composiciones farmaceuticas que contienen estos derivados.
ZA200805598B (en) Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
PT1718651E (pt) Derivados 7h-pirrolopirimidina
JO2296B1 (en) Substituted pyrolates
IL147901A0 (en) Phenanthroline-7-one derivatives and their therapeutic uses

Legal Events

Date Code Title Description
FG Grant or registration